United States · FDA National Drug Code directory
TRILYTE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84386-013_79f5e596-8d51-4227-afcc-f5e341150957
- Product NDC
- 84386-013
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- polyethylene glyocol 3350, sodium chloride, sodium bicarbonate and potassium chloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260414
- Source listing expiry
- 20271231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 420 g/4L
- SODIUM BICARBONATE — 5.72 g/4L
- SODIUM CHLORIDE — 11.2 g/4L
- POTASSIUM CHLORIDE — 1.48 g/4L
These values do not establish equivalence or a dose recommendation.
Packages
- 4 L in 1 BOTTLE (84386-013-04) · 84386-013-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →